Xtant Medical Holdings, Inc. - Common Stock (XTNT)
CUSIP: 98420P308
Q1 2019 13F Holders as of 31 Mar 2019
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 140,036,400
- Total 13F shares
- 11,662,801
- Share change
- -72,229
- Total reported value
- $35,571,000
- Price per share
- $3.05
- Number of holders
- 9
- Value change
- -$210,500
- Number of buys
- 1
- Number of sells
- 5
Quarterly Holders Quick Answers
What is CUSIP 98420P308?
CUSIP 98420P308 identifies XTNT - Xtant Medical Holdings, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 98420P308:
Top shareholders of XTNT - Xtant Medical Holdings, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
|
Company |
6.6%
|
9,207,012
|
$14,823,000 | — | 31 Dec 2018 | |
| Park West Asset Management LLC |
13F
|
Company |
0.9%
|
1,258,733
|
$2,027,000 | — | 31 Dec 2018 | |
| Telemetry Investments, L.L.C. |
13F
|
Company |
0.57%
|
796,826
|
$1,283,000 | — | 31 Dec 2018 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.24%
|
337,564
|
$543,000 | — | 31 Dec 2018 | |
| Bruce & Co., Inc. |
13F
|
Company |
—
class O/S missing
|
182,972
|
$334,000 | — | 31 Dec 2018 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.04%
|
56,048
|
$90,000 | — | 31 Dec 2018 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
50,000
|
$81,000 | — | 31 Dec 2018 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
10,824
|
$17,000 | — | 31 Dec 2018 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.01%
|
10,306
|
$16,000 | — | 31 Dec 2018 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
4,572
|
$7,000 | — | 31 Dec 2018 | |
| Winslow, Evans & Crocker, Inc. |
13F
|
Company |
0%
|
1,258
|
$4,000 | — | 31 Dec 2018 | |
| UBS Group AG |
13F
|
Company |
0%
|
1,887
|
$3,000 | — | 31 Dec 2018 |
Institutional Holders of Xtant Medical Holdings, Inc. - Common Stock (XTNT) as of Q1 2019
As of 31 Mar 2019,
Xtant Medical Holdings, Inc. - Common Stock (XTNT) was held by
9 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,662,801 shares.
The largest 9 holders included
ORBIMED ADVISORS LLC, Park West Asset Management LLC, Telemetry Investments, L.L.C., VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, BRIDGEWAY CAPITAL MANAGEMENT INC, MORGAN STANLEY, BlackRock Inc., and Winslow, Evans & Crocker, Inc..
This page lists
9
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2019 vs Q4 2018 Across Filers
Q4 2018 holders
11
Q1 2019 holders
9
Holder diff
-2
| Investor | Q4 2018 Shares | Q1 2019 Shares | Share Diff | Share Chg % | Q4 2018 Value $ | Q1 2019 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.